FDA — authorised 31 December 1985
- Application: NDA018859
- Marketing authorisation holder: BAUSCH
- Local brand name: VIRAZOLE
- Indication: FOR SOLUTION — INHALATION
- Status: approved
FDA authorised Virazole on 31 December 1985
Yes. FDA authorised it on 31 December 1985; FDA has authorised it.
BAUSCH holds the US marketing authorisation.